Everything keeps reverting back to safety and that is Brilacidin's ace in the hole. It is truly the double edged sword w/ efficacy on one side and a solid safety profile on the other.
Also what makes it lead the field IMO as a treatment choice.
(2)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links